FDA Investigator Kaitlyn T Dang

Kaitlyn T Dang has inspections in 1 countries as of 10 Feb 2023. Kaitlyn T Dang has collaborated with a combinined 455 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
21
Last Inspection Date:
10 Feb 2023
Investigator Role:
FDA Investigator
Redica ID:
100003560
Country:
United States of America
Co-Investigator(s):
Allen F Hall, Andrea A Branche, Angela Shepas, Cathy Condon, Cathy L Condon, Charles L Larson, Comyar Shoghi, Diane Cvan Leeuwen, Jonathan R Campos, Julian C Hanson, Katherine E Jacobitz, Kristin M Abaonza, Lakecha N Lewis, Leonard H Lavi, Lucas B Leake, Marlo Ianm Alintanahin, Michael D Garcia, Ni A Khin, MD, Ni Aye Khin, MD, Paul R Whitby, Phillip D Kronstein, Sandra L Shire, DMD, MPA, Tawny L Colling, William S Vitale, Yvonne T Lacour, Zerita White

Kaitlyn T Dang's Documents

Publish Date Document Type Title
January, 2021 FDA 483 Response Acadia Pharmaceuticals Inc. - Form 483R, 2021-02-11
December, 2020 EIR Samer K. Khaled, M.D. - EIR, 2020-12-23
January, 2022 EIR KITE PHARMA INC - EIR, 2022-01-28
May, 2021 EIR Immunity Bio, Inc - EIR, 2021-05-20
July, 2021 EIR Tim Wigal - EIR, 2021-07-22
December, 2020 FDA 483 Samer K. Khaled, M.D. - Form 483, 2020-12-23
January, 2021 FDA 483 Acadia Pharmaceuticals Inc. - Form 483, 2021-01-27
November, 2021 FDA 483 Valencia Technologies - Form 483, 2021-11-17
August, 2021 FDA 483 Chao-Ming C. Lu, MD - Form 483, 2021-08-13

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more